Related Experiment Video
Updated: Jun 10, 2026
09:07
Genetic Manipulation of Cerebellar Granule Neurons In Vitro and In Vivo to Study Neuronal Morphology and Migration
Published on: March 17, 2014
Gene transfer to the cerebellum.
Jean-Pierre Louboutin1, Beverly A S Reyes, Elisabeth J Van Bockstaele
1Department of Pathology, Jefferson Medical College, Thomas Jefferson University, 1020 Locust Street, Room 255, Philadelphia, PA 19107, USA. jplouboutin@hotmail.com
Cerebellum (London, England)
|August 12, 2010
Summary
Recombinant simian virus 40 (SV40)-derived vectors effectively deliver gene therapy to rat cerebellum. These safe and durable vectors primarily target Purkinje cells, showing potential for treating cerebellar diseases.
Area of Science:
- Neuroscience
- Gene Therapy
- Vectorology
Background:
- Gene transfer to the cerebellum holds promise for treating various neurological diseases.
- Recombinant Tag-deleted SV40-derived vectors (rSV40s) demonstrate efficient transduction of neurons and microglia in vitro and in vivo.
Purpose of the Study:
- To evaluate the efficacy, safety, and durability of rSV40 vectors for gene delivery to the cerebellum in vivo.
- To characterize the distribution, duration, and cell types transduced by rSV40 vectors in the rat cerebellum.
Main Methods:
- Stereotaxic injection of rSV40 vectors carrying a human immunodeficiency virus (HIV)-Nef transgene with a FLAG epitope into the rat cerebellum.
- Immunohistochemical assessment of transgene expression in serial brain sections at 1, 2, and 4 weeks post-injection.
- Identification of transduced cell types, including Purkinje cells (calbindin-positive), microglia, astrocytes, and oligodendrocytes.
Main Results:
- FLAG epitope-expressing cells were consistently detected in the cerebellum up to 4 weeks after vector administration.
- Transgene expression was predominantly observed in Purkinje cells, with occasional transduction of microglial cells.
- No transgene expression was detected in astrocytes or oligodendrocytes, and no inflammatory or adverse reactions were observed.
Conclusions:
- SV40-derived vectors are effective for gene transfer to the cerebellum.
- These vectors provide safe, durable, and targeted transgene expression, primarily in Purkinje cells.
- rSV40 vectors represent a promising tool for developing gene therapies for cerebellar disorders.
